186,161 Shares in Fresenius Medical Care AG (NYSE:FMS) Purchased by ABC Arbitrage SA

ABC Arbitrage SA bought a new position in Fresenius Medical Care AG (NYSE:FMS - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 186,161 shares of the company's stock, valued at approximately $4,215,000.

A number of other institutional investors and hedge funds have also bought and sold shares of FMS. Allworth Financial LP boosted its stake in shares of Fresenius Medical Care by 53.1% in the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company's stock valued at $36,000 after purchasing an additional 581 shares in the last quarter. MML Investors Services LLC boosted its position in Fresenius Medical Care by 5.3% during the third quarter. MML Investors Services LLC now owns 15,019 shares of the company's stock valued at $320,000 after buying an additional 753 shares during the period. DAVENPORT & Co LLC boosted its position in Fresenius Medical Care by 1.5% during the fourth quarter. DAVENPORT & Co LLC now owns 58,147 shares of the company's stock valued at $1,316,000 after buying an additional 862 shares during the period. Crossmark Global Holdings Inc. increased its holdings in shares of Fresenius Medical Care by 2.2% in the fourth quarter. Crossmark Global Holdings Inc. now owns 64,287 shares of the company's stock worth $1,456,000 after buying an additional 1,398 shares during the period. Finally, JPMorgan Chase & Co. increased its holdings in shares of Fresenius Medical Care by 18.2% in the third quarter. JPMorgan Chase & Co. now owns 9,902 shares of the company's stock worth $211,000 after buying an additional 1,528 shares during the period. 8.37% of the stock is currently owned by institutional investors.

Fresenius Medical Care Trading Down 1.6 %

Shares of FMS traded down $0.38 during mid-day trading on Wednesday, hitting $23.22. 192,769 shares of the company's stock traded hands, compared to its average volume of 233,874. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $13.63 billion, a P/E ratio of 19.19, a PEG ratio of 0.78 and a beta of 0.93. The business's 50-day moving average price is $23.45 and its 200-day moving average price is $21.61. Fresenius Medical Care AG has a 1 year low of $17.93 and a 1 year high of $25.25.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on FMS. Truist Financial raised their price target on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a "hold" rating in a research report on Monday, January 6th. StockNews.com raised shares of Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 5th. Bank of America raised shares of Fresenius Medical Care from an "underperform" rating to a "neutral" rating in a research report on Monday, December 2nd. Finally, Berenberg Bank assumed coverage on shares of Fresenius Medical Care in a research report on Wednesday, November 6th. They issued a "buy" rating and a $25.60 price objective on the stock.

Fresenius Medical Care Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.